The survival rate for patients affected by certain cancers has radically improved owing to the progress regarding advanced drugs within ATMP (Advanced Therapy Medicinal Products). To better reach patients, Karolinska Institutet and Karolinska University Hospital tie research, manufacturing, and clinic even more closely with the Karolinska ATMP Centre.
Read more about the Karolinska ATMP Centre in the interview with Stephan Mielke (Professor of Hematology and Cell Therapy at Karolinska Institutet and Department Head and Scientific Director at Karolinska University Hospital) and and Martin Bergö (Vice President of Karolinska Institutet).